|
|
||||||||
From the Stroke Program (Drs. Lisabeth and Brown), University of Michigan Health System, Ann Arbor; Michigan Peer Review Organization (MPRO) (Dr. Roychoudhury), Farmington Hills; and Stroke Program (Dr. Levine), Mount Sinai School of Medicine, New York, NY.
Address correspondence and reprint requests to Dr. Lynda Lisabeth, NI3D19300 North Ingalls, University of Michigan, Ann Arbor, MI 481090489; e-mail: llisabet{at}umich.edu
The authors examined the relationships between sex and race and antithrombotics prescribed at discharge in the Michigan Medicare population using retrospective medical record abstraction (n = 2,715) for the period January 1, 2001, to June 30, 2001. There were no differences in the use of antithrombotics at discharge by race or sex and no differences in the prescribing of aspirin, warfarin, aspirin/extended release dipyridamole, or clopidogrel by race or sex after adjustment for confounders.
Received November 26, 2003. Accepted in final form February 10, 2004.
This article has been cited by other articles:
![]() |
B. S. Jacobs, G. Birbeck, A. J. Mullard, S. Hickenbottom, R. Kothari, S. Roberts, and M. J. Reeves Quality of hospital care in African American and white patients with ischemic stroke and TIA Neurology, March 28, 2006; 66(6): 809 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brown, L. D. Lisabeth, C. Roychoudhury, Y. Ye, and L. B. Morgenstern Recurrent Stroke Risk Is Higher Than Cardiac Event Risk After Initial Stroke/Transient Ischemic Attack Stroke, June 1, 2005; 36(6): 1285 - 1287. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |